Table 1 Demographics.

From: Serum cytokines and inflammatory proteins in individuals with heroin use disorder: potential mechanistically based biomarkers for diagnosis

Variable

iHUD (n = 21)

HC (n = 24)

Group differences tests; Mann–Whitney U or Fisher’s exact test

Age: mean (95%CI)

42.0 (38.5–45.5)

40.7 (36.0–45.4)

NS

Sex: Male/Female

17 M/4 F

15 M/9 F

Fisher’s test; NS

Race: White/Black/Other

18/0/3

12/8/4

Fisher’s test; p = 0.006

Body mass index (BMI)

32.3 (29.4–35.3)

26.7 (24.9–28.6)

U = 110; p = 0.0009

Sleep hours in the night prior to the blood sample

6.54 (5.6–7.5)

6.51 (5.9–7.2)

NS

PSS-10 Perceived stress scorea;

Score range: 040

20.5 (17.7–23.3)

n = 20

12.3 (9.5–16.0)

U = 104; p = 0.001

BDI-II Depression scorea;

Score range: 063

15.5 (9.9–21.2)

n = 19

3.8 (1.8–5.7)

U = 78; p = 0.0001

BAI Anxiety scorea;

Score range: 063

14.1 (8.8–19.4)

n = 20

2.8 (1.1–4.4)

U = 85.5; p = 0.0001

Subjective opioid withdrawal scale (SOWS) at screening;

Score range: 064

4.1 (1.6–6.5)

N/A

 

Age of first use of heroinb

23.6 (17.4–27.8)

n = 20

N/A

N/A

Age of onset of regular use of heroinb

25.1 (21.2–28.9)

n = 20

N/A

N/A

Years of regular heroin useb

8.5 (5.9–11.2)

n = 19

N/A

N/A

Heroin abstinence duration in days

198 (130–268)

range: 1-634

N/A

N/A

Methadone daily dose in mgc

91.9 (63–121)

n = 16

N/A

N/A

Years of regular alcohol useb

12.3 (5.9–18.6)

n = 17

13.2 (6.6–19.8)

n = 18

NS

Years of regular cannabis useb

10.4 (5.9–14.9)

n = 15

1.3 (0.1–2.5)

n = 14

U = 85.5; p = 0.0001

  1. Frequencies or means and 95% CI (in parentheses) and the number of subjects are provided.
  2. Unless otherwise stated, n = 21 for iHUD (of which n = 17 with methadone and n = 4 with buprenorphine MAT), and n = 24 for HC; “n” varies due to missing data in specific variables.
  3. aIndividual PSS-10, BDI-II, and BAI scores are shown in Supplementary Fig. S1. “Floor” effects (i.e., a preponderance of “0” scores) were observed in the BDI-II and BAI scores in the HC group.
  4. bFrom the Addiction Severity Index (ASI).
  5. cBuprenorphine daily dose available from n = 3; mean = 13.3 mg (range 8–24; n = 3).